Search results for "Highlights"
Dapagliflozin associated with lower risk for all-cause mortality in type 2 diabetes regardless of CVD risk, study finds
The population-based retrospective cohort study included 22,124 type 2 diabetes patients from a British national primary care database, 4,444 of whom had taken dapagliflozin.
https://diabetes.acponline.org/archives/2017/03/10/2.htm
10 Mar 2017
Sickle cell trait affects HbA1c's accuracy as a measure of glycemia, study finds
Mean HbA1c was 5.7% in the African-American participants with sickle cell trait and 6.0% in those without, despite similar mean fasting and two-hour glucose values.
https://diabetes.acponline.org/archives/2017/02/10/2.htm
10 Feb 2017
Switching to sulfonylureas from metformin monotherapy may increase risk of cardiovascular, hypoglycemic events
The results suggest that continuing metformin alone and accepting higher HbA1c targets may be preferable to switching to sulfonylureas when considering macrovascular outcomes and hypoglycemia, an accompanying editorial said.
https://diabetes.acponline.org/archives/2018/08/10/1.htm
10 Aug 2018
Continuous glucose monitoring associated with lower HbA1c in type 1 diabetes treated with insulin injection
An editorial accompanying the two trials of continuous glucose monitoring stressed that the physicians involved had extensive experience with the technology and noted that the necessary changes in lifestyle and insulin dosing can be variable and complicated.
https://diabetes.acponline.org/archives/2017/02/10/3.htm
10 Feb 2017
Second-line therapies for type 2 diabetes may offer similar glycemic control
The only significant difference found by the meta-analysis was a small increase in myocardial infarction and eye disorders with sulfonylureas compared with dipeptidyl peptidase-4 inhibitors.
https://diabetes.acponline.org/archives/2018/09/14/1.htm
14 Sep 2018
Supplemental triglyceride-lowering therapy may lower CVD risk in statin-treated patients with diabetic dyslipidemia, study finds
The rate of nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes was 27% lower in participants with dyslipidemia randomized to fenofibrate than among those randomized to placebo.
https://diabetes.acponline.org/archives/2017/01/13/3.htm
13 Jan 2017
No apparent association between glycemic control, outcomes in diabetic nursing home residents
The study included patients 65 years of age and older with type 1 or type 2 diabetes admitted to a Veterans Affairs nursing home, and they were categorized by baseline HbA1c (6.0% to 6.9%, 7.0% to 7.9%, 8.0% to 8.9%, and 9.0% or higher).
https://diabetes.acponline.org/archives/2016/12/09/3.htm
9 Dec 2016
Commonly used blood glucose monitors may not always be accurate, study indicates
Researchers assessed the accuracy of 18 FDA-approved blood glucose monitoring systems, representing approximately 90% of those available in the U.S. from 2013 to 2015.
https://diabetes.acponline.org/archives/2018/07/13/1.htm
13 Jul 2018
Clinicians should integrate psychosocial components into diabetes care, ADA recommends
The position statement recommends that physicians consider assessing cognitive capacities and symptoms of diabetes distress, depression, anxiety, and disordered eating at the initial visit and at periodic intervals.
https://diabetes.acponline.org/archives/2016/12/09/2.htm
9 Dec 2016
Medicare finalizes policies to expand its Diabetes Prevention Program Model
The intervention for Medicare beneficiaries with prediabetes includes at least 16 weekly hour-long sessions over months 1 to 6 and at least 6 monthly maintenance sessions over months 6 to 12.
https://diabetes.acponline.org/archives/2016/11/11/2.htm
11 Nov 2016